written on 02.05.2014

Teva could jump into pharma's deal frenzy, CEO says


A few months ago, Teva CFO Eyal Desheh told the J.P. Morgan Healthcare Conference that armed with a new incoming CEO and a reasonable debt level, the Israeli company was ready to make some deals. So with an M&A wave taking the pharma industry by storm, where is Teva in the melee?